Hypertrophic cardiomyopathy is characterized by asymmetric hypertrophy of the ventricular walls and is mainly associated with factors such as familial inheritance and genetic mutations. Patients can be treated with medication, surgery and pacemaker placement.
1. Drug therapy: patients can use beta-blockers such as propranolol to increase the diastolic filling time of the ventricles and improve their symptoms. Non-dihydropyridine calcium channel blockers such as verapamil and diltiazem can also be used to improve ventricular diastolic function. If atrial fibrillation is present, oral anticoagulation with warfarin is also needed after evaluation.
2. Surgery: Patients who do not respond to medication may require septal septectomy or heart transplantation.
3. Placement of a pacemaker: Patients who do not respond well to medication and do not tolerate surgery may be able to improve their symptoms with the placement of a pacemaker.
It is recommended that patients go to the local hospital as soon as possible, actively cooperate with the doctor’s treatment, and use medication under the doctor’s guidance.